The Perth biobank giving hope to Western Australians with Mesothelioma
Western Australia has one of the highest rates of mesothelioma in the world – a legacy of decades of asbestos mining and use. For the past 30 years, the National Centre…
News
Annual Report 2024
The National Centre for Asbestos Related Diseases (NCARD) is proud to release its 2024 Annual Report. This year’s report highlights our research achievements, including: Discovery of blood biomarkers that can…
Dr Kirsten Bennett awarded scholarship for safer dust disease screening research
The National Centre for Asbestos Related Diseases (NCARD) is pleased to share that Dr Kirsten Bennett has received a $100,000 PhD scholarship from the Dust Diseases Board to advance research…
Welcoming Dr Chloe Choi to NCARD
We are delighted to welcome Dr Chloe Choi to the National Centre for Asbestos Related Diseases (NCARD) as a Research Associate. Dr Choi’s expertise in immunometabolism and natural killer (NK)…
Your Gift, Their Hope: NCARD Biobank Donors Drive Lifesaving Discoveries
More than 3,000 donors and their families have helped shape new tests, treatments and hope for the future. For over 30 years, the NCARD Biobank has quietly underpinned some of…
Creating super cell power
A new research centre is advancing cancer treatments by developing and testing RNA therapies that can be tailored to individual patients and tumours. Professor Archa Fox, from UWA’s School of…
Spotlight on: Dr Xiao Zhong
The National Centre for Asbestos-Related Diseases (NCARD) is pleased to spotlight Dr Xiao Zhong, a bioinformatician whose expertise is advancing our understanding of cancer immunology through computational analysis. Dr Zhong’s…
NCARD Secures Funding for Innovative Mesothelioma Imaging Study
The National Centre for Asbestos Related Diseases (NCARD) has been awarded $200,000 from the Medical Research Future Fund (MRFF) to support a new imaging trial for mesothelioma, an asbestos-related cancer.…